RETRACTED: Discoidin Domain Receptor 1 Contributes to the Survival of Lung Fibroblast in Idiopathic Pulmonary Fibrosis-Reference-Cited by-同舟云学术

RETRACTED: Discoidin Domain Receptor 1 Contributes to the Survival of Lung Fibroblast in Idiopathic Pulmonary Fibrosis

Published:2006-03 Issue:3 Volume:168 Page:866-877
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Matsuyama Wataru,Watanabe Masaki,Shirahama Yuko,Mitsuyama Hideo,Higashimoto Ikkou,Osame Mitsuhiro,Arimura Kimiyoshi

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference53 articles.

1. Idiopathic pulmonary fibrosis: clinical relevance of pathological classification;Katzenstein;Am J Respir Crit Care Med,1998

2. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis;Kuhn;Am J Pathol,1991

3. Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment;Khalil;CMAJ,2004

4. Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression;Ramos;Am J Respir Cell Mol Biol,2001

5. Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs;Moodley;Am J Respir Cell Mol Biol,2003

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancement of DDR1 and DDR2 Inhibitors: Therapeutic Potential of Bioactive Compounds, Designing Strategies, and Structure‐Activity Relationship (SAR);ChemistrySelect;2024-08-06

2. The Role of Fibroblasts in Atherosclerosis Progression;Fibroblasts - Advances in Inflammation, Autoimmunity and Cancer;2021-12-22

3. LncRNA-NR_033515 promotes proliferation, fibrogenesis and epithelial-to-mesenchymal transition by targeting miR-743b-5p in diabetic nephropathy;Biomedicine & Pharmacotherapy;2018-10

4. Forkhead Box F1 represses cell growth and inhibits COL1 and ARPC2 expression in lung fibroblasts in vitro;American Journal of Physiology-Lung Cellular and Molecular Physiology;2014-12-01

5. Hepatocyte growth factor is an attractive target for the treatment of pulmonary fibrosis;Expert Opinion on Investigational Drugs;2013-03-13